Viewing Study NCT05171335

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:17 PM
Ignite Modification Date: 2026-01-04 @ 7:32 AM
Study NCT ID: NCT05171335
Status: ENROLLING_BY_INVITATION
Last Update Posted: 2022-09-21
First Post: 2021-12-10
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Neoadjuvant Combination Therapy of Lenvatinib and TACE for Transplant-Eligible Large Hepatocellular Carcinoma Patients
Sponsor: The Methodist Hospital Research Institute
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hepatocellular Carcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None lenvatinib View
None Liver Transplantation View
None Neoadjuvant Therapy View
None Liver Neoplasms View
None liver cancer View
None liver cancer, adult View
None transplantation View
None Chemoembolization, Therapeutic View